Applicant, as named in the Orange Book

Btg Intl

Next listed expiry: Vistogard on 17 Aug 2027. 2 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Vistogard NDA 208159 uridine triacetate	uridine triacetate	17 Aug 2027 patent, carve-out possible	patent, carve-out possible
Aurlumyn NDA 217933 iloprost	iloprost	18 Jul 2044 patent, carve-out possible	patent, carve-out possible

Recent events

Vistogard · Enters 12-month window basis: patent, carve-out possibleListed date 17 Aug 2027Detected 24 Oct 2026

Products without listed protection (2)

Drug	Ingredient	Earliest generic entry	Basis
Cyanokit NDA 022041 hydroxocobalamin	hydroxocobalamin	open now no listed protection	no listed protection
Xuriden NDA 208169 uridine triacetate	uridine triacetate	open now no listed protection	no listed protection